Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | JAK3 | P52333 | 1/20 | 0.34 |
| ▸ | PDE9A | O76083 | 1/20 | 0.32 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22158461 | 0.91 | KDM4E (0.43) | KDM4EATML3MBTL1PDE9APDE1C | |
| SCHEMBL22156852 | 0.90 | KDM4E (0.38) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL22158398 | 0.88 | KDM4E (0.40) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL25903056 | 0.86 | KDM4E (0.43) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL20624035 | 0.85 | KDM4E (0.36) | KDM4EATML3MBTL1PDE9APDE1C | |
| SCHEMBL25903077 | 0.85 | KDM4E (0.42) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL24871591 | 0.85 | KDM4E (0.44) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL22156637 | 0.85 | KDM4E (0.39) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL21414303 | 0.84 | KDM4E (0.41) | KDM4EATML3MBTL1JAK2JAK3 | |
| SCHEMBL25903197 | 0.84 | KDM4E (0.41) | KDM4EATML3MBTL1JAK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | KDM4E 4239/4885ATM 4062/4885L3MBTL1 4126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.